Saturday 17 October 2026
Export EVO’s income statement to Excel — free account
Evotec AG
EVO Healthcare Drug Manufacturers Specialty & Generic
Evotec AG’s revenue for fiscal 2025 (year ended December 2025) was $892.0 million, up 3.43% from fiscal 2024. In the quarter to June 2026, revenue fell 13.0%, EPS fell 328.9%, free cash flow fell 9,727.2% and total debt rose 5.48%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.
1.38
0.04
−2.82%
Follow EVO
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
4 | — | 4 | — |
| (17.69%) | (12.00%) | (25.46%) | 0.00% | ||
| (8.30%) | (5.84%) | (11.42%) | 0.00% | ||
ROIC |
(5.47%) | (4.47%) | (17.80%) | 0.00% | |
Return on Tangible Assets |
(15.38%) | (10.90%) | (23.64%) | 0.00% | |
Average Days of Receivables |
72.08 | 80.75 | 65.09 | 0.00 | |
Free Cash Flow per Share |
(0.30) | (0.29) | (0.18) | 0.00 | |
Free Cash Flow |
(107.07) | (103.62) | (64.32) | (200.23) | |
Capital Expenditures |
(103.26) | (93.24) | (82.86) | (66.63) | |
| Other line items | |||||
Cash ROIC |
(6.43%) | (5.27%) | (3.81%) | (10.72%) | |
Accounts Receivable Turnover |
3.66 | 4.84 | 4.76 | 0.00 | |
Accounts Payable Turnover |
11.06 | 9.18 | 11.89 | 0.00 | |
Inventory Turnover |
19.66 | 22.82 | 20.73 | 0.00 | |
Average Days of Payables |
28.34 | 35.06 | 30.62 | 0.00 | |
Days of Inventory on Hand |
17.86 | 15.87 | 18.40 | 0.00 | |
Tax Rate |
0.20 | 0.19 | 0.08 | — | |
Research and Development Expense of Revenue |
4.94% | 4.76% | 4.96% | — | |
Selling, General and Administrative Expense of Revenue |
24.03% | 22.32% | 23.14% | — | |
Share Based Compensation of Revenue |
0.00% | 3.30% | 0.00% | — | |
Operating CF/Net income |
0.02 | 0.09 | (0.08) | 0.00 | |
Depreciation/Fixed assets |
0.00 | 0.35 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | (0.42) | 0.00 | 0.00 | |
Revenue per Share |
2.34 | 2.51 | 2.43 | — | |
Operating CF per Share |
(0.01) | (0.03) | 0.05 | 0.00 | |
Capex per Share |
(0.29) | (0.26) | (0.23) | 0.00 | |
Capex to Sales |
0.12 | 0.10 | 0.10 | 0.00 |
Columns are period end dates